Concepedia

Paola Coco

PC

14

Publications

804

Citations

12

H-Index

2005

Active since

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

European Institute of Oncology

Bayer (Germany)

Helsinki University Hospital

Novartis (Italy)

Paola Coco is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in oncology, medicine, and cancer therapeutics.

Top concepts

Publications per year

2005–2022

14

Publications

14

Surgery of Residual Disease Following Molecular-targeted Therapy With Imatinib Mesylate in Advanced/Metastatic GIST

Alessandro Gronchi, Marco Fiore, Francesca Miselli et al. · Annals of Surgery · 2007 · 245 citations · Full text

A Novel Tyrosine-Kinase Selective Inhibitor, Sunitinib, Induces Transient Hypothyroidism by Blocking Iodine Uptake

Deborah Mannavola, Paola Coco, Guia Vannucchi et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 225 citations

Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study

Heikki Joensuu, Filippo de Braud, G Grignagni et al. · British Journal of Cancer · 2011 · 77 citations · Full text

Phase II, open-label study of PTK787/ZK222584 for the treatment of metastatic gastrointestinal stromal tumors resistant to imatinib mesylate

Heikki Joensuu, Filippo de Braud, Paola Coco et al. · Annals of Oncology · 2007 · 62 citations · Full text

, , +5

Patterns of Care, Prognosis, and Survival in Patients with Metastatic Gastrointestinal Stromal Tumors (GIST) Refractory to First-Line Imatinib and Second-Line Sunitinib

Antoîne Italiano, Angela Cioffi, Paola Coco et al. · Annals of Surgical Oncology · 2011 · 60 citations

, , +6

Rows per page

1–5 of 14